BIOHLDG BIOALPHA HOLDINGS BERHAD
BIOHLDG scores 29/100 on fundamentals: in the bottom 15% of 1120 scored Bursa Malaysia stocks. Its strongest area is Financial Safety (67/100); its weakest is Business Strength (0/100). It carries 2 warning flags: Weak Spot, Recent Loss.
- Carries a Weak Spot flag
- Carries a Recent Loss flag
Nearby peers
Ranks #207 of 241 in Consumer Products & Services by score
One-Minute Summary
Why BIOHLDG scores 29
An expensively priced stock with shrinking sales, but business strength needs attention.
After Jun '26 results: 31 → 31See all movers →
Business StrengthLowest pillar
0Why 0?
Show 3 charts
Net Profit & Equity, with ROE
Revenue & Net Profit, with Net Margin
Sales shrank about 76.4% over 4 years: the business is getting smaller, which needs a good explanation.
The company lost money in recent years: the bars below zero are losses, not profits.
Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)
Sales fell about 93.1% over the last 8 quarters: worth watching why.
The company made a loss in at least one of the last 8 quarters: the bars below zero are losses, not profits.
Financial Safety
67Why 67?
Show 2 charts
Debt vs Equity, with D/E ratio
Borrowings fell about 68.9% over 4 years: the company is steadily getting safer.
Short-term assets vs bills, with Current Ratio
Cash & Dividends
13Why 13?
Show 3 charts
Operating vs Free Cash Flow
Cash flow has been weak or negative recently: the business is burning cash, not building it.
Cash vs Total Debt
Dividends per Share, with Yield
Dividends per share have been maintained or raised: management shares the rewards with you.
Price Fairness
33Why 33?
Show chart
Score vs Share Price
The share price has been roughly flat over the past year.
What happened, and how the price moved
- 30 Aug 2026Bioalpha Holdings Malaysia 2nd-Quarter 2026 Earnings Summary Table · 富途牛牛Week▼33.3%KLCI −0.6%Month▲33.3%KLCI −4.1%
Risk
33Why 33?
Show chart
Revenue vs Inventory, with Inventory % of Revenue
Get an email when BIOHLDG's score changes, and why
Own more than one stock? Check them all at once ›Sector peers
BIOHLDG (0179.KL) scores 29/100 (Weak) on Score Your Stock's educational fundamentals model: in the bottom 15% of 1120 scored Bursa Malaysia stocks.
Its strongest pillar is Financial Safety (67/100); its weakest is Business Strength (0/100).
BIOHLDG ranks #207 of 241 scored Consumer Products & Services stocks on Score Your Stock.
BIOHLDG (0179.KL) has not paid a dividend in the last 12 months.
Open a trading account and a CDS account with any Bursa Malaysia broker, then place a buy order for 0179.KL in lots of 100 shares. Broker fees for the same trade differ a lot between brokers: compare them for your trade size at https://scoreyourstock.com/tools/brokerage-fee-calculator.
The overall score pools every measure across 5 weighted pillars: Business Strength, Financial Safety, Cash & Dividends, Price Fairness, and Risk (for banks, Financial Safety checks impaired loans, loan loss coverage and the CET1 capital ratio instead of debt and liquidity). Full methodology, the default weights, and how to set your own: https://scoreyourstock.com/how. This is an educational tool, not investment advice.
Makes and markets health supplements and functional foods, runs the Constant pharmacy chain, and sells into Malaysia, Indonesia and China. On Score Your Stock's fundamentals check, it scores 29/100, rated Weak. Its biggest strength is Financial Safety (67/100); its main watch-out is Business Strength (0/100). Full breakdown and daily-updated score: https://scoreyourstock.com/stocks/klse/0179-biohldg
Full Financial History
Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.
| Financial Year | Revenue | Net Profit | Operating Cash Flow | Free Cash Flow | CapEx | Cash | Total Debt | Short-Term Debt | Equity | Current Assets | Current Liabilities | Total Assets | Total Liabilities | Inventory | Dividends | Return on Equity (ROE) | Net Profit Margin | Debt-to-Equity | Current Ratio | Interest Coverage | Div yield | P/E Ratio | P/B Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | RM 10.9m | RM -19.8m | RM -2.0m | RM -2.3m | RM -0.4m | RM 3.2m | RM 3.7m | RM 0.4m | RM 65.1m | RM 23.4m | RM 6.7m | RM 73.8m | RM 9.4m | RM 3.3m | - | -30% | -182% | 0.1× | 3.5× | -106.1× | - | - | - |
| 2025 | RM 11.5m | RM -29.7m | RM -5.8m | RM -6.3m | RM -0.4m | RM 3.6m | RM 4.6m | RM 0.3m | RM 69.3m | RM 26.5m | RM 7.0m | RM 79.1m | RM 10.8m | RM 3.7m | RM 0.0m | -43% | -258% | 0.1× | 3.8× | -135.2× | 0% | -1.2× | 0.5× |
| 2024 | RM 62.0m | RM -48.6m | RM 0.1m | RM -2.2m | RM -2.3m | RM 7.2m | RM 5.3m | RM 0.4m | RM 98.3m | RM 48.5m | RM 13.1m | RM 119.0m | RM 21.3m | RM 3.8m | RM 0.0m | -49% | -78% | 0.1× | 3.7× | -155.0× | 0% | -1.7× | 0.9× |
| 2023 | RM 46.1m | RM -42.0m | RM 1.2m | RM -2.1m | RM -3.4m | RM 10.4m | RM 11.9m | RM 4.0m | RM 127.4m | RM 52.8m | RM 21.7m | RM 163.2m | RM 33.6m | RM 6.8m | RM 0.0m | -33% | -91% | 0.1× | 2.4× | -64.9× | 0% | -3.7× | 1.2× |